Literature DB >> 17192628

Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype.

Angelo O Rosa1, Javier Egea, Luís Gandía, Manuela G López, Antonio G García.   

Abstract

Nicotine (NIC) is neuroprotective against glutamate and hypoxia-induced neurotoxicity, preventing neuronal death and apoptosis in primary neuronal cultures. This effect is mediated by activation of both alpha7 and alpha4beta2 subtypes of nicotinic receptors for acetylcholine (nAChR) (Kaneko et al., 1997; Hejmadi et al., 2003). Furthermore, it seems that activation of alpha7 nAChR is the mechanism by which galantamine protects against thapsigargin and beta-amyloid-induced cell death (Arias et al., 2004), as well as in neuroprotection exerted by NIC against tumor necrosis factor alpha (Gahring et al., 2003). In this context we studied possible protection produced by NIC in an oxygen-glucose deprivation (OGD) model of rat and mouse hippocampal slices. The involvement of alpha7 nAChR in neuroprotection was proved by using wild-type and alpha7 knockout (KO) mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192628     DOI: 10.1385/JMN:30:1:61

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  5 in total

1.  Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors.

Authors:  S Kaneko; T Maeda; T Kume; H Kochiyama; A Akaike; S Shimohama; J Kimura
Journal:  Brain Res       Date:  1997-08-08       Impact factor: 3.252

2.  Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation.

Authors:  Mónica Sobrado; José M Roda; Manuela G López; Javier Egea; Antonio G García
Journal:  Neurosci Lett       Date:  2004-07-22       Impact factor: 3.046

3.  Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.

Authors:  Esperanza Arias; Eva Alés; Nelson H Gabilan; María F Cano-Abad; Mercedes Villarroya; Antonio G García; Manuela G López
Journal:  Neuropharmacology       Date:  2004-01       Impact factor: 5.250

4.  Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes.

Authors:  M V Hejmadi; F Dajas-Bailador; S M Barns; B Jones; S Wonnacott
Journal:  Mol Cell Neurosci       Date:  2003-11       Impact factor: 4.314

5.  Nicotine-induced neuroprotection against N-methyl-D-aspartic acid or beta-amyloid peptide occur through independent mechanisms distinguished by pro-inflammatory cytokines.

Authors:  Lorise C Gahring; Erin L Meyer; Scott W Rogers
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

  5 in total
  14 in total

Review 1.  Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance.

Authors:  Merouane Bencherif
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

2.  Boosting Endogenous Resistance of Brain to Ischemia.

Authors:  Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

3.  Preventing expression of the nicotinic receptor subunit α7 in SH-SY5Y cells with interference RNA indicates that this receptor may protect against the neurotoxicity of Aβ.

Authors:  Xiao-Lan Qi; Kai Ou-Yang; Jia-Mou Ren; Chang-Xue Wu; Yan Xiao; Yi Li; Zhi-Zhong Guan
Journal:  Neurochem Res       Date:  2013-02-21       Impact factor: 3.996

4.  The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.

Authors:  Tanuja Bordia; Matthew McGregor; Roger L Papke; Michael W Decker; J Michael McIntosh; Maryka Quik
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

Review 5.  α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

Authors:  Victor V Uteshev
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 6.  Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.

Authors:  Maryka Quik; Danhui Zhang; Matthew McGregor; Tanuja Bordia
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

7.  Cardiovascular effects of black tea and nicotine alone or in combination against experimental induced heart injury.

Authors:  Siyavash Joukar; Hamideh Bashiri; Shahriar Dabiri; Payam Ghotbi; Arash Sarveazad; Kouros Divsalar; Farzin Joukar; Mahsa Abbaszadeh
Journal:  J Physiol Biochem       Date:  2012-01-07       Impact factor: 4.158

8.  A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Authors:  Bopanna I Kalappa; Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 9.  Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.

Authors:  Akinori Akaike; Yuki Takada-Takatori; Toshiaki Kume; Yasuhiko Izumi
Journal:  J Mol Neurosci       Date:  2010-01       Impact factor: 3.444

10.  Differential responses of hippocampal neurons and astrocytes to nicotine and hypoxia in the fetal guinea pig.

Authors:  Tamara Blutstein; Michael A Castello; Shaun S Viechweg; Maria M Hadjimarkou; Joseph A McQuail; Mary Holder; Loren P Thompson; Jessica A Mong
Journal:  Neurotox Res       Date:  2012-11-29       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.